Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View ALT insider activity ↗

ALTAltimmune, Inc.

THE LATEST REPORTED YEAR

The company reported a loss.

$88.09M net loss for the year ended December 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$41KYear ended December 31, 2025
Profit or loss-$88.09MYear ended December 31, 2025
Cash from the business-$67.54MYear ended December 31, 2025
Total assets$527.21MAs of June 30, 2026
Total liabilities$53MAs of June 30, 2026
Cash & equivalents$63.01MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$20.99M
2010-12
$24.27M
2011-12
$4.41M
2021-12
-$68K
2022-12
$426K
2023-12
$20K
2024-12
$41K
2025-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2025 – December 31, 2025$41,000March 6, 202610-K ↗
January 1, 2024 – December 31, 2024$20,000March 6, 202610-K ↗
January 1, 2023 – December 31, 2023$426,000February 27, 202510-K ↗
January 1, 2022 – December 31, 2022-$68,000March 27, 202410-K ↗
January 1, 2021 – December 31, 2021$4,410,000February 28, 202310-K ↗
January 1, 2011 – December 31, 2011$24,266,274March 8, 201210-K ↗
January 1, 2010 – December 31, 2010$20,993,605March 8, 201210-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:Revenues · Retrieved October 15, 2026

Response SHA-256: 4deefcd740dbf05da53c5853a294a420ace2130450e24520c45c3b3e6bd673d0

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.